Massachusetts General Hospital Mass General — Boston, Massachusetts

Massachusetts General Hospital Mass General is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital Mass General has participated in 8 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Tumors Characterized by Genetic Abnormalities of ALK.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital Mass General?

Massachusetts General Hospital Mass General has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital Mass General conducted?

Massachusetts General Hospital Mass General has 8 clinical trials on record. Their work covers Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Tumors Characterized by Genetic Abnormalities of ALK.

Is Massachusetts General Hospital Mass General accredited by Crixeo Health?

Massachusetts General Hospital Mass General has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital Mass General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.